Key result
Total arterial myocardial revascularization provided a significantly higher mean long-term survival of 18.7 years compared to 10.44 years for venous grafts in patients undergoing isolated CABG.
Why the study?
Graft conduit types and surgical techniques may impact long-term outcomes after CABG revascularization, prompting observation of long-term survival over 20 years in the UK.
Does total arterial myocardial revascularization improve long-term survival compared to mixed or venous grafts in patients undergoing isolated CABG?
Cohort (n=2,979)
No
Does total arterial myocardial revascularization improve long-term survival compared to mixed or venous grafts in patients undergoing isolated CABG?
Absolute Event Rate: 18.7% vs 10.44%
May favor total arterial grafts for CABG survival; hypothesis-generating and requires randomized confirmation.
BACKGROUND: The types of graft conduits and surgical techniques may impact the long-term outcomes of patients after coronary artery bypass graft (CABG) revascularization. This study observed a long-term survival rate following CABG surgery over 20 years in the United Kingdom. METHODS: A total of 2979 isolated CABG patients were studied from 1999 to 2020, and postoperative data were obtained from the hospital-recorded mortality by the data quality team of the information department. Postdischarge survival was estimated using the Kaplan-Meier method, and statistical significance was obtained with log-rank tests and the Gehan-Breslow test, and the Holm-Sidak method was used for multiple pairwise comparisons. RESULTS: The study observed male predominance (80%), and the median age was statistically significant (P <0.001) among the groups, 66 years (interquartile range 58-73) and 72 years (interquartile range 66-78) in survivor and non-survivor groups, respectively. In the Holm-Sidak method analysis, the best survival rate (mean 18.7 years) was observed in the total arterial group with significantly decreased survival for the mixed arterial and venous group (mean 16.12 years) and only the vein group (10.44 years). The Cox regression model observed that the New York Heart Association (NYHA) class III-IV (HR 1.57), chest re-exploration (HR 2.14), preoperative dialysis (HR 3.13), and redo surgery (HR 3.04) were potential predictors of the postoperative mortality (P ≤0.05). CONCLUSION: In our series over 20 years, albeit off-pump and on-pump CABG observed similar survival rates, the total arterial myocardial revascularization population has significantly better long-term survival benefits.
No takes yet. Share an insight, caveat, or question.
Momin et al. (2023) conducted a cohort in Ischemic heart disease requiring isolated CABG (n=2,979). Total arterial myocardial revascularization vs. Mixed arterio-venous grafts or only venous grafts was evaluated on Long-term survival. Total arterial myocardial revascularization provided a significantly higher mean long-term survival of 18.7 years compared to 10.44 years for venous grafts in patients undergoing isolated CABG.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: